SO
DSGN icon

STRS Ohio’s Design Therapeutics DSGN Stock Holding History

STRS Ohio’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$476K Buy
44,700
+19,500
+77% +$197K ﹤0.01% 1107
2025
Q4 		$236K Buy
25,200
+2,600
+12% +$20.4K ﹤0.01% 1450
2025
Q3 		$170K Hold
22,600
– – ﹤0.01% 1618
2025
Q2 		$76.2K Hold
22,600
– – ﹤0.01% 1944
2025
Q1 		$87.2K Sell
22,600
-10,000
-31% -$47.7K ﹤0.01% 1694
2024
Q4 		$201K Hold
32,600
– – ﹤0.01% 1510
2024
Q3 		$175K Hold
32,600
– – ﹤0.01% 1593
2024
Q2 		$109K Buy
32,600
+3,300
+11% +$12.9K ﹤0.01% 1684
2024
Q1 		$118K Sell
29,300
-43,500
-60% -$116K ﹤0.01% 1656
2023
Q4 		$192K Hold
72,800
– – ﹤0.01% 1573
2023
Q3 		$171K Buy
+72,800
New +$340K ﹤0.01% 1601
2021
Q4 		– Sell
-2,000
Closed -$29K – 2222
2021
Q3 		$29K Sell
2,000
-1,100
-35% -$18.3K ﹤0.01% 2146
2021
Q2 		$61K Buy
+3,100
New +$78.2K ﹤0.01% 2073

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

STRS Ohio's DSGN Position: Q1 2026 in Review

STRS Ohio increased its Design Therapeutics (DSGN) stake by 77% in Q1 2026, buying an estimated $197K and bringing the position to 44,700 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

STRS Ohio first reported a position in DSGN in Q2 2021 and has held it in 13 quarters since. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • STRS Ohio held 44,700 shares of Design Therapeutics worth $476K as of Q1 2026.
  • STRS Ohio bought 19,500 Design Therapeutics shares in Q1 2026, an estimated $197K.
  • Design Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1107 holding.
  • STRS Ohio first reported a position in Design Therapeutics in Q2 2021 and has held it in 13 quarters since.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.